Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Costimulatory molecules are a heterogeneous group of cell-surface and transmembrane proteins expressed mainly on antigen-presenting cells such as dendritic cells and B cells; they provide essential secondary signals (beyond antigen recognition) required for full T cell activation, function, and fate decisions. Key families include the B7 family (CD80/B7-1, CD86/B7-2), TNF receptor/ligand family (e.g., CD40, OX40L), among others. These molecules can deliver either activating or inhibitory signals, thereby shaping immune responses towards activation (immunity), tolerance, or regulation, and are therefore important therapeutic targets in cancer, transplantation, and autoimmune diseases. However, “costimulatory molecules” is a collective term; further specification is required to reference an individual drug target molecule.
Immune checkpoint inhibition or blockade (e.g., blocking CTLA-4 or PD-1/PD-L1 pathways); Costimulatory blockade (e.g., abatacept prevents costimulation of T cells by binding CD80/CD86); Modulation of T cell activation—either enhancing or suppressing immune responses
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Costimulatory molecule.